Bad Data, Bad AI, Big Problems: Why GenAI is Critical for Pharma’s Future
Imagine a scenario where an AI model, trained on incomplete or inaccurate data, misguides a pharmaceutical company in predicting adverse drug reactions. The result? A new medication, expected to save lives, instead causes unforeseen complications, leading to a mass recall and patient harm. Studies show that a majority of AI models fail due to poor… Read More
